BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31697849)

  • 1. Protein Abundance of Hepatic Drug Transporters in Patients With Different Forms of Liver Damage.
    Drozdzik M; Szelag-Pieniek S; Post M; Zeair S; Wrzesinski M; Kurzawski M; Prieto J; Oswald S
    Clin Pharmacol Ther; 2020 May; 107(5):1138-1148. PubMed ID: 31697849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Abundance of Drug Transporters in Human Hepatitis C Livers.
    Droździk M; Lapczuk-Romanska J; Wenzel C; Skalski Ł; Szeląg-Pieniek S; Post M; Syczewska M; Kurzawski M; Oswald S
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.
    Wang L; Collins C; Kelly EJ; Chu X; Ray AS; Salphati L; Xiao G; Lee C; Lai Y; Liao M; Mathias A; Evers R; Humphreys W; Hop CE; Kumer SC; Unadkat JD
    Drug Metab Dispos; 2016 Nov; 44(11):1752-1758. PubMed ID: 27543206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics.
    Billington S; Ray AS; Salphati L; Xiao G; Chu X; Humphreys WG; Liao M; Lee CA; Mathias A; Hop CECA; Rowbottom C; Evers R; Lai Y; Kelly EJ; Prasad B; Unadkat JD
    Drug Metab Dispos; 2018 Feb; 46(2):189-196. PubMed ID: 29138286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers.
    Kurzawski M; Szeląg-Pieniek S; Łapczuk-Romańska J; Wrzesiński M; Sieńko J; Oswald S; Droździk M
    Pharmacol Rep; 2019 Aug; 71(4):738-745. PubMed ID: 31207436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
    Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
    Clin Pharmacol Ther; 2019 May; 105(5):1204-1212. PubMed ID: 30447067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics.
    Wang L; Prasad B; Salphati L; Chu X; Gupta A; Hop CE; Evers R; Unadkat JD
    Drug Metab Dispos; 2015 Mar; 43(3):367-74. PubMed ID: 25534768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
    Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rapid and sensitive multiple reaction monitoring proteomic approach for quantification of transporters in human liver tissue.
    Wang L; Rubadue KJ; Alberts J; Bedwell DW; Ruterbories KJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():356-363. PubMed ID: 28800539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of human liver membrane transporters: a focus on fetuses and newborn infants.
    van Groen BD; van de Steeg E; Mooij MG; van Lipzig MMH; de Koning BAE; Verdijk RM; Wortelboer HM; Gaedigk R; Bi C; Leeder JS; van Schaik RHN; van Rosmalen J; Tibboel D; Vaes WH; de Wildt SN
    Eur J Pharm Sci; 2018 Nov; 124():217-227. PubMed ID: 30171984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
    Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
    J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine.
    Mayati A; Moreau A; Denizot C; Stieger B; Parmentier Y; Fardel O
    Eur J Pharm Sci; 2017 Aug; 106():302-312. PubMed ID: 28603032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation.
    Vildhede A; Nguyen C; Erickson BK; Kunz RC; Jones R; Kimoto E; Bourbonais F; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2018 May; 46(5):692-696. PubMed ID: 29439128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP.
    König J; Klatt S; Dilger K; Fromm MF
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):81-6. PubMed ID: 22333292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.
    Sayyed K; Vee ML; Abdel-Razzak Z; Jouan E; Stieger B; Denizot C; Parmentier Y; Fardel O
    Toxicology; 2016 Jul; 363-364():58-71. PubMed ID: 27450509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Orally Administered Borneol on the Expression of Hepatic Transporters in Rats.
    Chen L; Liao L; Zhai T; Huang X; Chen Y
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):103-109. PubMed ID: 30105488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.
    Kojima H; Nies AT; König J; Hagmann W; Spring H; Uemura M; Fukui H; Keppler D
    J Hepatol; 2003 Nov; 39(5):693-702. PubMed ID: 14568249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.